Tania Jong

Co-founder, Deputy Chair and Executive Director of Mind Medicine Australia, the mental-health charity she founded with her husband, Peter Hunt. An award-winning Australian social entrepreneur and soprano, de Jong has helped advance clinical education, advocacy and access for psychedelic-assisted therapies, including the successful rescheduling of MDMA and psilocybin in Australia.

Australia Opened a Restricted Prescribing Pathway for MDMA and Psilocybin

Mind Medicine Australia co-founder Tania de Jong argues that Australia’s 2023 decision to permit tightly controlled prescribing of MDMA for PTSD and psilocybin for treatment-resistant depression was won not by a single regulatory application, but by building the clinical, political and public infrastructure around it. Her account is a procedural one: revise rejected submissions against regulators’ objections, mobilize patients and clinicians, recruit scientific allies, train a workforce before approval and prepare systems for data collection and payment. The result remains a restricted psychiatric pathway, not broad legalization—and its durability now depends on whether access can expand without compromising supervision or affordability.

Tim FerrissSep 19, 202617 min read